SCHEMBL31544232

SCHEMBL31544232

COC(=O)c1cc(Cl)nc2ccc(Br)cc12

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.71
KDM4E B2RXH2 2/20 0.68
ALDH1A1 P00352 3/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HTT P42858 2/20 0.50
TSHR P16473 1/20 0.50
PLA2G2A P14555 4/20 0.49
MAPT P10636 2/20 0.49
ATM Q13315 1/20 0.49
POLB P06746 1/20 0.49
GAA P10253 1/20 0.49
NR4A2 P43354 1/20 0.49
CHEK1 O14757 1/20 0.47
DHODH Q02127 3/20 0.46
ABCG2 Q9UNQ0 1/20 0.45
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
KMT2A Q03164 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27030353 0.89 KDM4E (0.68) L3MBTL1KDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL22468805 0.85 KDM4E (0.71) L3MBTL1KDM4EALDH1A1HTTPLA2G2A
SCHEMBL30758183 0.84 L3MBTL1 (0.72) L3MBTL1KDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL16832230 0.84 L3MBTL1 (0.72) L3MBTL1KDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL31266680 0.83 DHODH (0.62) L3MBTL1KDM4EALDH1A1HTTMAPT
SCHEMBL11894679 0.83 KDM4E (0.68) L3MBTL1KDM4EALDH1A1HTTPLA2G2A
SCHEMBL28840836 0.83 L3MBTL1 (0.71) L3MBTL1KDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL20472457 0.83 KDM4E (0.68) L3MBTL1KDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL2348562 0.82 ALDH1A1 (0.50) L3MBTL1KDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL30365659 0.81 KDM4E (1.00) KDM4EALDH1A1HTTMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025098450-A1 PRMT5 INHIBITOR AND PREPARATION METHOD THEREFOR 北京泰德制药股份有限公司 2025-05-15 WO disclosed